Flatmark K - Search Results

1

A Three-dimensional Ex Vivo Viability Assay Reveals a Strong Correlation Between Response to Targeted Inhibitors and Mutation Status in Melanoma Lymph Node Metastases.

Flørenes VA, Flem-Karlsen K, McFadden E, Bergheim IR, Nygaard V, Nygård V, Farstad IN, Øy GF, Emilsen E, Giller-Fleten K, Ree AH, Flatmark K, Gullestad HP, Hermann R, Ryder T, Wernhoff P, Mælandsmo GM. Flørenes VA, et al. Among authors: flatmark k. Transl Oncol. 2019 Jul;12(7):951-958. doi: 10.1016/j.tranon.2019.04.001. Epub 2019 May 13. Transl Oncol. 2019. PMID: 31096111 Free PMC article.

2

Nuclear localization of the metastasis-related protein S100A4 correlates with tumour stage in colorectal cancer.

Flatmark K, Pedersen KB, Nesland JM, Rasmussen H, Aamodt G, Mikalsen SO, Bjørnland K, Fodstad Ø, Maelandsmo GM. Flatmark K, et al. J Pathol. 2003 Aug;200(5):589-95. doi: 10.1002/path.1381. J Pathol. 2003. PMID: 12898594

3

Immunofluorometric assay for the metastasis-related protein S100A4: release of S100A4 from normal blood cells prohibits the use of S100A4 as a tumor marker in plasma and serum.

Flatmark K, Maelandsmo GM, Mikalsen SO, Nustad K, Varaas T, Rasmussen H, Meling GI, Fodstad Ø, Paus E. Flatmark K, et al. Tumour Biol. 2004 Jan-Apr;25(1-2):31-40. doi: 10.1159/000077721. Tumour Biol. 2004. PMID: 15192310

4

Twelve colorectal cancer cell lines exhibit highly variable growth and metastatic capacities in an orthotopic model in nude mice.

Flatmark K, Maelandsmo GM, Martinsen M, Rasmussen H, Fodstad Ø. Flatmark K, et al. Eur J Cancer. 2004 Jul;40(10):1593-8. doi: 10.1016/j.ejca.2004.02.023. Eur J Cancer. 2004. PMID: 15196545

5

Matrix metalloproteinases participate in osteosarcoma invasion.

Bjørnland K, Flatmark K, Pettersen S, Aaasen AO, Fodstad O, Maelandsmo GM. Bjørnland K, et al. Among authors: flatmark k. J Surg Res. 2005 Aug;127(2):151-6. doi: 10.1016/j.jss.2004.12.016. Epub 2005 Apr 14. J Surg Res. 2005. PMID: 16083752

6

DNA damage responses in cell cycle G2 phase and mitosis--tracking and targeting.

Ree AH, Stokke T, Bratland A, Patzke S, Nome RV, Folkvord S, Meza-Zepeda LA, Flatmark K, Fodstad O, Andersson Y. Ree AH, et al. Among authors: flatmark k. Anticancer Res. 2006 May-Jun;26(3A):1909-16. Anticancer Res. 2006. PMID: 16827124 Free article.

7

Radiosensitization of colorectal carcinoma cell lines by histone deacetylase inhibition.

Flatmark K, Nome RV, Folkvord S, Bratland A, Rasmussen H, Ellefsen MS, Fodstad Ø, Ree AH. Flatmark K, et al. Radiat Oncol. 2006 Aug 3;1:25. doi: 10.1186/1748-717X-1-25. Radiat Oncol. 2006. PMID: 16887021 Free PMC article.

8

Inhibitory effects of oxaliplatin in experimental radiation treatment of colorectal carcinoma: does oxaliplatin improve 5-fluorouracil-dependent radiosensitivity?

Folkvord S, Flatmark K, Seierstad T, Røe K, Rasmussen H, Ree AH. Folkvord S, et al. Among authors: flatmark k. Radiother Oncol. 2008 Mar;86(3):428-34. doi: 10.1016/j.radonc.2007.10.012. Epub 2007 Nov 19. Radiother Oncol. 2008. PMID: 18006097

9

HDAC2 deficiency and histone acetylation.

Ree AH, Folkvord S, Flatmark K. Ree AH, et al. Among authors: flatmark k. Nat Genet. 2008 Jul;40(7):812-3; author reply 813. doi: 10.1038/ng0708-812. Nat Genet. 2008. PMID: 18583969 No abstract available.

10

Different expression and clinical role of S100A4 in serous ovarian carcinoma at different anatomic sites.

Maelandsmo GM, Flørenes VA, Nguyen MT, Flatmark K, Davidson B. Maelandsmo GM, et al. Among authors: flatmark k. Tumour Biol. 2009;30(1):15-25. doi: 10.1159/000199447. Epub 2009 Feb 5. Tumour Biol. 2009. PMID: 19194111

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

156 results

Search Page